Novartis’ Cox-II challenger suffers set back
October 28, 2003Prexige, the new challenger to the established Cox-II drugs from Novartis has been dealt a serious blow after the FDA …
Hassan takes on Schering-Plough revival
October 28, 2003Fred Hassan has outlined his plans to turn round the fortunes of struggling Schering-Plough after being installed as the company's …
Swiss franc undercuts Roche growth
October 28, 2003Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …
Ageing atypical could help cut suicide levels
October 28, 2003Novartis' atypical antipsychotic Clozaril could lead to a reduction in suicide rate among patients suffering from schizophrenia, according to a …
Patent system damaging research
October 28, 2003The UK patent system is damaging scientific research and creating a old rush mentality according to the Royal Society.The current …
Human genome sequence completed
October 28, 2003The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …
GSK claims victory in US parallel import row
October 27, 2003GlaxoSmithKline has claimed victory in its controversial bid to block parallel imports of its drugs from Canada into the US.The …
Swiss franc undercuts Roche growth
October 27, 2003Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …
Patent system damaging research
October 27, 2003The UK patent system is damaging scientific research and creating a "gold rush mentality", according to the Royal Society.The current …
Human genome sequence completed
October 27, 2003The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …
Humira launch costs hit Abbott
October 27, 2003Abbott Labs recorded a 6% drop in profits for the first quarter of 2003 following heavy spending on the launch …
Set back for GSK in Augmentin court battle
October 27, 2003GlaxoSmithKline has suffered a set back in its bid to see off early US generic competition for antibiotic Augmentin, one …
MEPs vote to ban embryonic stem cell research
October 27, 2003European MPs have voted to ban the use of human cloning and embryonic stem cells for research purposes.The vote could …
Latest content
FibroFind appoints Lee Borthwick as CEO
